NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 655901 | ANTINEOPLASTIC-655901 | 0.0174989034030623 | -0.02767762 |
NSC 656206 | Discorhabdin I | 0.0174989034030623 | 0.23607197 |
NSC 661940 | 2-(2-chloroethoxy)naphthazarin | 0.0174989034030623 | 0.11872899 |
NSC 665925 | Null | 0.0174989034030623 | 0.23726317 |
NSC 669020 | Null | 0.0174989034030623 | -0.075738169 |
NSC 67586 | 2-Naphthacenecarboxamide, N-[[(6,7-dihydro-7-oxo-1H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl)amino]methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, | 0.0174989034030623 | -0.10368107 |
NSC 676963 | 3-Azido-10-[4-(4-(4-benzoylphenyl)methyl)-1-piperazinyl)butyl]phenothiazine, bismaleate salt | 0.0174989034030623 | 0.20217059 |
NSC 680094 | 17-(O-Diethylaminoethyl)oximino-3-methoxy-1,3,5(10)- estratriene hydrochloride | 0.0174989034030623 | 0.1708121 |
NSC 682768 | Null | 0.0174989034030623 | 0.05878565 |
NSC 683086 | Boronic acid, [3-methyl-1-[[1-oxo-4-phenyl- 2-[[(2-quinolinyl)carbonyl]amino]butyl]amino]butyl]- | 0.0174989034030623 | -0.029357515 |